Ryan van de Graaff, MD
Otolaryngology · Boise, IDNPI 1619067436
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Med-el Corporation accounts for 93.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $5,126 and has fallen 96.1% since, to $199 in 2025. Among otolaryngology clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $229.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Med-el Corporation$5K
- Cochlear Americas$141
- Stryker$61
- Integra Lifesciences Corporation$25
- Sanofi$20
- Amgen$19
- plus $75 from 5 others
What the payments were for
- Speaking & faculty fees$3,00055%
- Travel & lodging$1,53328%
- Food & beverage$96918%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Med-el Corporation | 12 | $5,161 |
| Cochlear Americas | 2 | $141 |
| Stryker | 2 | $61 |
| Integra Lifesciences Corporation | 1 | $25 |
| Sanofi | 1 | $20 |
| Amgen | 1 | $19 |
| Medtronic | 1 | $17 |
| Novartis | 1 | $17 |
| Acclarent, Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
| Lucid Diagnostics Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,503 in reported general payments places this provider in the 90th percentile of 40 otolaryngology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 92 | $2,547 |
| Ofloxacin | 47 | $2,288 |
| Omeprazole | 145 | $1,462 |
| Fluocinolone Acetonide Oil | 29 | $1,399 |
| Azelastine Hcl | 52 | $947 |
| Pantoprazole Sodium | 57 | $843 |
| Fluticasone Propionate | 49 | $735 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 56 | $536 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 36 | $265 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 40 | $254 |
| Famotidine | 24 | $213 |
| Mupirocin | 18 | $113 |
| Methylprednisolone | 12 | $105 |
| Prednisone | 31 | $103 |
| Tramadol Hcl | 17 | $43 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Boise
- Donald BeasleyBoise$7K
- Tyson NielsenBoise$1K
- David LewisBoise$911
- Martin TubachBoise$245
- John SymmsBoise$238
- Jacob RobisonBoise$147
- Todd RustadBoise$55
- Matthew SchwarzBoise$32
- Arthur JonesBoise$19
- Delray MaughanBoise$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.